Herwig Gerlach

Department of Anesthesiology, Operative Intensive Care and Pain Management, Vivantes - Klinikum Neukoelln, Germany

Herwig Gerlach

Director of the Clinic for Anesthesiology and Critical Care Medicine.

Education: He carried out his undergraduate study at the Ubbo Emmius College, Leer where he graduated with B.S. Physics, 1975. Subsequently he went on to attain his M.D from Justus Liebig University, Giessen, 1981. Finally he obtained his Ph.D from Columbia University, NY, 1990.

Research Interests: Include Cell biology; pathomechanisms of inflammation; cytokines and specific inhibitory therapies; multicenter clinical trials in sepsis therapies; nitric oxide in ARDS.

Professional Employment:
-Professor and Chairman, Vivantes – Klinikum Neukoelln (since 2002).
-Professor, Ass. Medical Director, Charité, Humboldt University (1998-2001).
-Division Chief, Critical Care Medicine, Virchow Clinic, (1993-1997).
-Consultant, Anesthetist, Westend Clinic, Free University, Berlin (1990-1992).
-Postdoc Research Fellow, Columbia University, New York (1988-1990).
-Anesthesiology Resident, Heine University Clinic, Duesseldorf (1986-1987).
-Anesthesiology Fellow, Liebig University Clinic, Giessen, (1981-1986).

Teaching Experience: Professor Gerlach has given numerous presentations including seminars; practical courses and lectures taken from an extensive knowledge of Anesthesiology, Emergency medicine, Postoperative care medicine and Physiology.

Other information: He chairs many of the renowned Anesthesiology and Critical care Medicine organizations in Germany and has first or senior authored 49 publications, 22 chapters and co-authored 45 books. He has also given a number of invited lectures.
He has received numerous awards including Annual Scientific Award 1999 (1. Price) of the 19th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium: "Effects of hydrocortisone stress-dose therapy in septic shock: monocyte HLA-DR expression and blood interferon-g concentration. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study"; being the most recent.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Critical Care & Emergency Medicine > Sepsis & Multiple Organ Failure in Critical Care (since 14 November 2005)

All recent recommendations

• 4.8
  Delirium as a predictor of long-term cognitive impairment in survivors of critical illness.
  Recommended by Herwig Gerlach, Jim O'Brien with Hallie Prescott
  
• 9.0
  Effectiveness of Treatments for Severe Sepsis: A Prospective Multicenter Observational Study.
  Recommended by Herwig Gerlach
  
• 3.0
  Preserved cerebral microcirculation during cardiogenic shock.
  Recommended by Herwig Gerlach with Susanne Toussaint
  
• 6.0
  Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.
  Recommended by Herwig Gerlach with Susanne Toussaint
  
• 6.0
  2007 American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock*
  Recommended by Herwig Gerlach with Susanne Toussaint
  
• 6.6
  Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.
  Recommended by Bruce Bistrian, Herwig Gerlach with Susanne Toussaint, Jim O'Brien with Hallie Prescott, John Augoustides with Prakash Patel
  
• 4.8
  Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.
  Recommended by Herwig Gerlach with Susanne Toussaint, Marcelo Gama de Abreu
  
• 3.0
  Eosinopenia is a reliable marker of sepsis on admission in medical intensive care units.
  Recommended by Herwig Gerlach with Susanne Toussaint
  
• 6.0
  Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis.
  Recommended by Herwig Gerlach with Susanne Toussaint
  
• 4.8
  Severe hypoglycemia in critically ill patients: risk factors and outcomes.
  Recommended by Herwig Gerlach with Susanne Toussaint, Jean-Charles Preiser
  
• 4.8
  Trauma-associated lung injury differs clinically and biologically from acute lung injury owing to other clinical disorders*
  Recommended by Greg Martin, Herwig Gerlach with Susanne Toussaint
  
• 6.0
  A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients.
  Recommended by Herwig Gerlach
  
• 4.8
  Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease.
  Recommended by Herwig Gerlach, Alain Vuylsteke
  
• 6.0
  A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial.
  Recommended by Herwig Gerlach
  
• 4.8
  From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest.
  Recommended by Naoto Morimura, Herwig Gerlach
  
• 6.0
  Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis.
  Recommended by Herwig Gerlach
  
• 6.0
  Pediatric in-intensive-care-unit cardiac arrest: incidence, survival, and predictive factors.
  Recommended by Herwig Gerlach
  
• 4.8
  Omega-3 fatty acids improve the diagnosis-related clinical outcome.
  Recommended by Herwig Gerlach, Jean-Charles Preiser
  
• 3.0
  Mean glucose level is not an independent risk factor for mortality in mixed ICU patients.
  Recommended by Herwig Gerlach
  
• 6.4
  L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study.
  Recommended by Paul van Leeuwen, Herwig Gerlach